Associate Director, HCP Marketing, Bylvay (Rare Disease)

Location: Cambridge, United States

Annual base salary: $161,250–$236,500

Company

hirify.global is a global biopharmaceutical company focused on transformative medicines in oncology, rare disease, and neuroscience.

What you will do

• Lead peer-to-peer marketing initiatives for Bylvay, including congresses, speaker bureaus, and advisory boards.
• Develop and execute congress marketing plans, speaker bureau content, training, and ongoing operations.
• Create promotional materials, messages, and multichannel engagement tactics for healthcare professionals.
• Develop and monitor KPIs for brand tactical plans and communicate performance to Rare Disease leadership.
• Contribute to brand planning and tactical plan development across the Rare Disease portfolio.
• Coordinate with field leadership, sales training, medical affairs, legal, business ethics, analytics, and other marketing teams.

Requirements

• At least 10 years of biopharmaceutical commercial experience, including at least 5 years in pharmaceutical or biotechnology commercial marketing.
• Successful launch experience in rare or specialty categories; sales or field-based experience is strongly preferred.
• Proven cross-functional leadership, stakeholder management, communication, and project management skills.
• Strong scientific and medical aptitude, with significant knowledge of rare diseases, complex science, and reimbursement.
• Experience managing projects, vendors, and large budgets, along with knowledge of AMA, ACCME, PhRMA, and FDA promotional requirements.
• Bachelor’s degree or equivalent required; PharmD or MBA preferred.

Culture & Benefits

• Employee position with comprehensive benefits and company-contributed 401(k).
• Medical, dental, vision, life, disability, and flexible spending benefits.
• Parental leave, paid time off, discretionary winter shutdown, well-being allowance, and commuter benefits.
• Collaborative workplace focused on inclusion, equal opportunity, professional growth, and patient impact.